The International Partnership for Microbicides (IPM) is a nonprofit committed to developing safe and effective microbicides and making them available in developing countries, where women are at greatest risk of infection.
Vaginal microbicides are products being developed to prevent HIV transmission during sex. They offer women a new method to prevent infection.
IPM is accelerating microbicide development by bringing together private sector technologies and public sector resources. IPM has engaged major pharmaceutical companies and partners with them to identify the most promising antiretroviral drugs. The microbicides being developed by IPM are based on antiretroviral medicines—the very drugs proven successful in treating HIV infection.
Developing a microbicide is complex and requires extensive research and collaboration with scientists, policymakers
and advocates, and participation by thousands of clinical trial volunteers in communities where HIV and AIDS are most prevalent.
8401 Colesville Road Suite 200 Silver Spring, MD 20910